Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 94 entries
View as:

Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA

Phase: N/A Priority: Normal
NCT ID: NCT00535041 Org: User:
Start: 09/30/07 End: 09/30/15 Due: 09/30/16

Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections

Phase: N/A Priority: Normal
NCT ID: NCT05258851 Org: User:
Start: 06/01/22 End: 01/28/24 Due: 01/28/25

The Effectiveness of Radial Shockwave Therapy on Myofascial Pain Syndrome in Neck and Upper Back.

Phase: N/A Priority: Normal
NCT ID: NCT05381987 Org: User:
Start: 04/21/22 End: 04/30/24 Due: 04/30/25

A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

Phase: N/A Priority: Normal
NCT ID: NCT00531544 Org: User:
Start: 02/28/07 End: 06/30/12 Due: 06/30/13

Clinical Outcomes in Fenestrated Extra-Cardiac Fontan in Low Preoperative Risk Profiles

Phase: N/A Priority: Normal
NCT ID: NCT03503032 Org: User:
Start: 04/01/23 End: 04/12/23 Due: 04/12/24

Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to Present

Phase: N/A Priority: Normal
NCT ID: NCT00534755 Org: User:
Start: 06/30/05 End: 06/30/15 Due: 06/30/16

Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT06062706 Org: User:
Start: 08/06/23 End: 10/30/23 Due: 10/30/24

Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT04404127 Org: User:
Start: 09/01/20 End: 05/31/25 Due: 05/31/26

Change in Management Following Bronchoscopy in Hematopoietic Stem Cell Transplant Patients With Pulmonary Infiltrates

Phase: N/A Priority: Normal
NCT ID: NCT04998903 Org: User:
Start: 05/01/16 End: 02/27/20 Due: 02/27/21

Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01608464 Org: User:
Start: 05/31/12 End: 09/30/15 Due: 09/30/16

Degludec Insulin Use in Critically Ill Patients

Phase: N/A Priority: Normal
NCT ID: NCT06056167 Org: User:
Start: 05/17/23 End: 05/30/24 Due: 05/30/25

Study to Assess Incidence of ONJ in Pts With Bone Mets Starting Zoledronic Acid Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01488851 Org: User:
Start: 01/31/12 End: 01/31/15 Due: 01/31/16

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN)

Phase: N/A Priority: Normal
NCT ID: NCT02216799 Org: User:
Start: 03/31/13 End: 08/31/15 Due: 08/31/16

Modafinil for Wakefulness in the Critical Care Units

Phase: N/A Priority: Normal
NCT ID: NCT04751227 Org: User:
Start: 11/22/20 End: 01/30/21 Due: 01/30/22

COVID-19 Pathophysiology of Long Term Implications

Phase: N/A Priority: Normal
NCT ID: NCT04813575 Org: User:
Start: 08/01/21 End: 06/01/22 Due: 06/01/23

Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00534950 Org: User:
Start: 09/30/07 End: 09/30/15 Due: 09/30/16

Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca

Phase: N/A Priority: Normal
NCT ID: NCT00944424 Org: User:
Start: 07/31/09 End: 07/31/12 Due: 07/31/13

Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi Arabia

Phase: N/A Priority: Normal
NCT ID: NCT02884713 Org: User:
Start: 06/30/13 End: 04/30/14 Due: 04/30/15

Criteria for Accessory Vein Obliteration Trial.

Phase: N/A Priority: Normal
NCT ID: NCT02632942 Org: User:
Start: 09/30/15 End: 12/31/18 Due: 12/31/19

Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)

Phase: N/A Priority: Normal
NCT ID: NCT02919371 Org: User:
Start: 12/31/14 End: 12/31/21 Due: 12/31/22

Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00538525 Org: User:
Start: 09/30/07 End: 04/30/08 Due: 04/30/09

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Phase: N/A Priority: Normal
NCT ID: NCT00537901 Org: User:
Start: 10/31/07 End: 10/31/13 Due: 10/31/14

Hypertonic Saline for COVID-19 Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT04465604 Org: User:
Start: 02/01/21 End: 05/31/22 Due: 05/31/23

Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01530594 Org: User:
Start: 01/31/09 End: 01/31/13 Due: 01/31/14

Establishment of Acute Lymphocytic Leukemia Data Base in the Department of Oncology

Phase: N/A Priority: Normal
NCT ID: NCT01310946 Org: User:
Start: 06/30/03 End: - Due: -